WO2001039725A3 - Preparations de medicaments - Google Patents

Preparations de medicaments Download PDF

Info

Publication number
WO2001039725A3
WO2001039725A3 PCT/US2000/041961 US0041961W WO0139725A3 WO 2001039725 A3 WO2001039725 A3 WO 2001039725A3 US 0041961 W US0041961 W US 0041961W WO 0139725 A3 WO0139725 A3 WO 0139725A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug preparations
compositions
preparations
drug
semisolid
Prior art date
Application number
PCT/US2000/041961
Other languages
English (en)
Other versions
WO2001039725A2 (fr
Inventor
Alan Drizen
Michael Micalizzi
Original Assignee
L A M Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L A M Pharmaceutical Corp filed Critical L A M Pharmaceutical Corp
Priority to AU45042/01A priority Critical patent/AU4504201A/en
Priority to EP00992485A priority patent/EP1231897A2/fr
Priority to CA002390841A priority patent/CA2390841A1/fr
Publication of WO2001039725A2 publication Critical patent/WO2001039725A2/fr
Publication of WO2001039725A3 publication Critical patent/WO2001039725A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions semi-solides de médicaments à libération lente basées sur l'acide hyaluronique et es sels, et concerne plus particulièrement la fabrication et l'utilisation de telles compositions.
PCT/US2000/041961 1999-11-08 2000-11-08 Preparations de medicaments WO2001039725A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU45042/01A AU4504201A (en) 1999-11-08 2000-11-08 Drug preparations
EP00992485A EP1231897A2 (fr) 1999-11-08 2000-11-08 Preparations de medicaments
CA002390841A CA2390841A1 (fr) 1999-11-08 2000-11-08 Preparations de medicaments

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16414999P 1999-11-08 1999-11-08
US60/164,149 1999-11-08

Publications (2)

Publication Number Publication Date
WO2001039725A2 WO2001039725A2 (fr) 2001-06-07
WO2001039725A3 true WO2001039725A3 (fr) 2002-05-10

Family

ID=22593194

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/041961 WO2001039725A2 (fr) 1999-11-08 2000-11-08 Preparations de medicaments

Country Status (4)

Country Link
EP (1) EP1231897A2 (fr)
AU (1) AU4504201A (fr)
CA (1) CA2390841A1 (fr)
WO (1) WO2001039725A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972636B2 (en) 2004-02-25 2011-07-05 Hidemoto Kusaka Beverage and medicament containing bamboo extract as a main ingredient
WO2005079824A1 (fr) * 2004-02-25 2005-09-01 Hidemoto Kusaka Boisson ou médicament contenant des extraits de bambou comme ingrédient principal
US8497303B2 (en) 2008-01-18 2013-07-30 Dow Global Technologies Llc Method to enhance aqueous solubility of poorly soluble actives

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059123A (en) * 1990-05-14 1991-10-22 Jernberg Gary R Periodontal barrier and method for aiding periodontal tissue regeneration
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059123A (en) * 1990-05-14 1991-10-22 Jernberg Gary R Periodontal barrier and method for aiding periodontal tissue regeneration
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals

Also Published As

Publication number Publication date
CA2390841A1 (fr) 2001-06-07
AU4504201A (en) 2001-06-12
EP1231897A2 (fr) 2002-08-21
WO2001039725A2 (fr) 2001-06-07

Similar Documents

Publication Publication Date Title
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO1999053910A3 (fr) Compositions pharmaceutiques contenant de l'acide folique, procedes et systemes d'administration correspondants
WO2002070438A3 (fr) Compositions permettant l'administration de biophosphonates
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
EP1391200A4 (fr) Preparations de medicaments
MX9700885A (es) Nuevas heteroariloxazolidinonas.
IL148288A0 (en) Indolealkanol ester and indolealkylamide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HK1046134A1 (en) Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them.
AU3850600A (en) Dalda analogs and their use
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
WO2002015959A3 (fr) Composes et compositions permettant de distribuer des agents actifs
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2002000208A3 (fr) Preparations de derives d'acide 3-n-formylhydroxylaminopropylphosphonique ou de derives d'acide 3-n-acetylhydroxylaminopropylphosphonique combines avec des principes actifs pharmaceutiques speciaux
WO2001039725A3 (fr) Preparations de medicaments
AU9270598A (en) Hydrazono-benzazulene derivatives, pharmaceutical compositions and in termediates
ZA200110244B (en) Novel xanthone compounds, their preparation and use as medicament.
WO2001068676A3 (fr) Nouveaux antagonistes de la lhrh, sa production et son utilisation comme medicament
AU2001260110A1 (en) Novel LHRH-antagonists, Production and Use Thereof as Medicament
AU6027899A (en) Local delivery of medications to the heart
WO1998038994A3 (fr) Preparation combinee d'acide 2-methylthiazolidine-2,4-dicarboxylique et de paracetamol
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WPC Withdrawal of priority claims after completion of the technical preparations for international publication
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2390841

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2000992485

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000992485

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000992485

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP